Dealagdon, Edgar D.

HRN: 29-14-99  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/16/2026
06/23/2026
IV
600mg
Q8H
NON HEALING WOUND
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines